2 recruiting, 1 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 2, Completed 1 |
Follow Upper Tract Urothelial Carcinoma: new trials by email Literature Review of Upper Tract Urothelial Carcinoma trials Research Report on Upper Tract Urothelial Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma EB-DT-NK-UC101, Cyclophosphamide, Fludarabine - Bladder Cancer, Urothelial Carcinoma | Phase 1 | Recruiting | Beijing Biotech | 42 | 2026-03-02 | 2026-03-25 |
| Ambulatory Flexible URS for UTUC Surveillance Ambulatory flexible ureterorenoscopy - Upper Tract Urothelial Carcinoma | Phase 1 | Recruiting | Chinese University of Hong Kong | 10 | 2025-07-01 | 2025-09-15 |
| Treatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11) WST11 mediated vascular targeted phototherapy (VTP), Endoscopy - Upper Tract Urothelial Carcinoma | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 30 | 2018-08-01 | 2025-07-18 |
Carcinoma, Transitional Cell (1) · Urinary Bladder Neoplasms (1)
Carcinoma (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Urinary Bladder Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Urologic Diseases (1) · Urologic Neoplasms (1)
Cyclophosphamide (1) · Endoscopy (1) · fludarabine (1)
Beijing Biotech (1) · Chinese University of Hong Kong (1) · Memorial Sloan Kettering Cancer Center (1)
China (1) · Hong Kong (1) · United States (1)